UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antithrombotic effects of factor Xa inhibition with DU-176b: Phase-I study of an oral, direct factor Xa inhibitor using an ex-vivo flow chamber

Thrombosis and haemostasis, 2007-10, Vol.98 (4), p.883-888

2007

Volltextzugriff (PDF)

Antithrombotic Therapy for Coronary Artery Disease

Chest, 2004-09, Vol.126 (3), p.513S-548S

2004

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease

JAMA : the journal of the American Medical Association, 1999-04, Vol.281 (15), p.1407

1999

Volltextzugriff (PDF)

Exploring the Changes in Code Status During the COVID-19 Pandemic and the Implications for Future Pandemic Care

American journal of hospice & palliative medicine, 2022-11, Vol.39 (11), p.1364-1370

2022

Volltextzugriff (PDF)

The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

Chest, 2008-06, Vol.133 (6 Suppl), p.776S-814S

2008

Volltextzugriff (PDF)

Platelets in Atherothrombosis

Mayo Clinic proceedings, 2006, Vol.81 (1), p.59-68

2006

Volltextzugriff (PDF)

The Primary and Secondary Prevention of Coronary Artery Disease

Chest, 2008-06, Vol.133 (6), p.776S-814S

2008

Volltextzugriff (PDF)

Increased risk of stroke and mortality following new-onset atrial fibrillation during hospitalization

Europace (London, England), 2017-06, Vol.19 (6), p.929-936

2017

Volltextzugriff (PDF)

NOVEL ORAL ANTICOAGULANT AVAILABILITY INCREASES APPROPRIATE USE OF ANTICOAGULANTS FOR NONVALVULAR ATRIAL FIBRILLATION IN CLINICAL PRACTICE

Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.787-787

2016

Volltextzugriff (PDF)

Antithrombotic therapy for coronary artery disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Chest, 2004-09, Vol.126 (3), p.513S-548S

2004

Volltextzugriff (PDF)

Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease

Circulation (New York, N.Y.), 2008-06, Vol.117 (22), p.2865-2874

2008

Volltextzugriff (PDF)

Ticagrelor reduces thrombus formation more than clopidogrel, even when co-administered with bivalirudin

Thrombosis and haemostasis, 2014-11, Vol.112 (5), p.1069-1070

2014

Volltextzugriff (PDF)

DABIGATRAN VERSUS STANDARD ANTITHROMBOTIC THERAPY FOR NEW ONSET NONVALVULAR ATRIAL FIBRILLATION: IMPACT ON HOSPITAL LENGTH OF STAY

Journal of the American College of Cardiology, 2013-03, Vol.61 (10), p.E377-E377

2013

Volltextzugriff (PDF)

INCREASED MORTALITY IN PATIENTS ADMITTED OVER THE WEEKEND WITH COMPLETE HEART BLOCK, AN ANALYSIS FROM THE NATIONAL INPATIENT SAMPLE 2001-2013

Journal of the American College of Cardiology, 2023-03, Vol.81 (8), p.25-25

2023

Volltextzugriff (PDF)

A new oral antiplatelet agent with potent antithrombotic properties: comparison of DZ-697b with clopidogrel a randomised phase I study

Thrombosis and haemostasis, 2010-01, Vol.103 (1), p.205-212

2010

Volltextzugriff (PDF)

TICAGRELOR ASSOCIATED ACQUIRED HEMOPHILIA A AND HEMORRHAGIC SHOCK POST CORONARY STENTING

Journal of the American College of Cardiology, 2024-04, Vol.83 (13), p.3354-3354

2024

Volltextzugriff (PDF)

What is QT interval prolongation?

The Journal of family practice, 2005-06, Vol.54 (6), p.SSS4

Vorchheimer, David A

2005

Volltextzugriff (PDF)

Multi-bed vascular disease and atherothrombosis: scope of the problem

Journal of thrombosis and thrombolysis, 2004-02, Vol.17 (1), p.51-61

2004

Volltextzugriff (PDF)

ANTIPHOSPHOLIPID SYNDROME INDUCED TRICUSPID VALVE ENDOCARDITIS, A RARE CASE PRESENTATION

Journal of the American College of Cardiology, 2023-03, Vol.81 (8), p.3728-3728

2023

Volltextzugriff (PDF)

Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes : Prospective analysis from PURSUIT

Circulation (New York, N.Y.), 2001-07, Vol.104 (4), p.399-405

2001

Volltextzugriff (PDF)

Abstract 11383: Automated Measurement of Global Longitudinal Strain by Speckle-Tracking Echocardiography in Cardio-Oncology Patients Using Artificial Intelligence

Circulation (New York, N.Y.), 2021-11, Vol.144 (Suppl_1)

2021

Volltextzugriff (PDF)

Sirolimus-eluting stent placement for refractory renal artery in-stent restenosis: sustained patency and clinical benefit at 24 months

Vascular medicine (London, England), 2009-11, Vol.14 (4), p.361-364

2009

Volltextzugriff (PDF)

Oral platelet glycoprotein IIb/IIIa receptor antagonists: the present challenge is safety

Circulation (New York, N.Y.), 1998-02, Vol.97 (4), p.312-314

1998

Volltextzugriff (PDF)

Prevention of Atherosclerosis in Coronary-Artery Bypass Grafts

The New England journal of medicine, 1997-01, Vol.336 (3), p.212-213

1997

Volltextzugriff (PDF)

Inflammatory markers in coronary artery disease: let prevention douse the flames

JAMA : the journal of the American Medical Association, 2001-11, Vol.286 (17), p.2154

2001

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Englisch
(67)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Antithrombotic effects of factor Xa inhibition with DU-176b: Phase-I study of an oral, direct factor Xa inhibitor using an ex-vivo flow chamber

Antithrombotic Therapy for Coronary Artery Disease

Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease

Exploring the Changes in Code Status During the COVID-19 Pandemic and the Implications for Future Pandemic Care

The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

Platelets in Atherothrombosis

The Primary and Secondary Prevention of Coronary Artery Disease

Increased risk of stroke and mortality following new-onset atrial fibrillation during hospitalization

NOVEL ORAL ANTICOAGULANT AVAILABILITY INCREASES APPROPRIATE USE OF ANTICOAGULANTS FOR NONVALVULAR ATRIAL FIBRILLATION IN CLINICAL PRACTICE

Antithrombotic therapy for coronary artery disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease

Ticagrelor reduces thrombus formation more than clopidogrel, even when co-administered with bivalirudin

DABIGATRAN VERSUS STANDARD ANTITHROMBOTIC THERAPY FOR NEW ONSET NONVALVULAR ATRIAL FIBRILLATION: IMPACT ON HOSPITAL LENGTH OF STAY

INCREASED MORTALITY IN PATIENTS ADMITTED OVER THE WEEKEND WITH COMPLETE HEART BLOCK, AN ANALYSIS FROM THE NATIONAL INPATIENT SAMPLE 2001-2013

A new oral antiplatelet agent with potent antithrombotic properties: comparison of DZ-697b with clopidogrel a randomised phase I study

TICAGRELOR ASSOCIATED ACQUIRED HEMOPHILIA A AND HEMORRHAGIC SHOCK POST CORONARY STENTING

What is QT interval prolongation?

Multi-bed vascular disease and atherothrombosis: scope of the problem

ANTIPHOSPHOLIPID SYNDROME INDUCED TRICUSPID VALVE ENDOCARDITIS, A RARE CASE PRESENTATION

Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes : Prospective analysis from PURSUIT

Abstract 11383: Automated Measurement of Global Longitudinal Strain by Speckle-Tracking Echocardiography in Cardio-Oncology Patients Using Artificial Intelligence

Sirolimus-eluting stent placement for refractory renal artery in-stent restenosis: sustained patency and clinical benefit at 24 months

Oral platelet glycoprotein IIb/IIIa receptor antagonists: the present challenge is safety

Prevention of Atherosclerosis in Coronary-Artery Bypass Grafts

Inflammatory markers in coronary artery disease: let prevention douse the flames

Suchergebnisse filtern